Genomenon Partners With Alexion To Help Genetic Testing Labs Diagnose Rare Diseases
ANN ARBOR - Genomenon, an AI-driven genomics company, announced it will collaborate with Alexion, AstraZeneca Rare Disease to make critical information needed for the diagnosis and treatment for a set of rare diseases more readily accessible. The goal of this collaboration is to empower genetic testing labs with the data they need to diagnose patients
